Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study

por McDermott, Raymond S., Greene, John, McCaffrey, John, Parker, Imelda, Helanova, Sylva, Baird, Anne-Marie, Teiserskiene, Ausra, Lim, Marvin, Matthews, Helen, Deignan, Olwyn, Feeney, John, Thirion, Pierre G., Finn, Stephen P., Kelly, Paul J.
Publicado 2021